Biofrontera AG: Ludwig Lutter appointed new Chief Financial Officer effective March 1, 2021
02. Februar 2021 10:35 ET
|
Biofrontera AG
Leverkusen, Germany, Feb. 02, 2021 (GLOBE NEWSWIRE) -- The Supervisory Board of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical...
Biofrontera announces conference call to be held on August 27, 2020 to discuss half-year 2020 financial results
19. August 2020 04:30 ET
|
Biofrontera AG
Leverkusen, Germany, Aug. 19, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
Supervisory Board of Biofrontera AG renews Management Board appointment
23. Juli 2020 08:30 ET
|
Biofrontera AG
Leverkusen, Germany, July 23, 2020 (GLOBE NEWSWIRE) -- The Supervisory Board of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today...
Biofrontera reports preliminary unaudited sales revenue for the first six months of 2019
09. Juli 2019 12:05 ET
|
Biofrontera AG
Leverkusen, Germany, July 09, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-group”), an international biopharmaceutical...
Biofrontera to Present at Two Upcoming Investor Conferences
12. Juni 2019 10:58 ET
|
Biofrontera AG
Leverkusen, Germany, June 12, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that...
Biofrontera to Participate in Two Upcoming Investor Conferences
26. November 2018 13:08 ET
|
Biofrontera AG
Leverkusen, Germany, Nov. 26, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced its...
Biofrontera to Present at the Cantor Fitzgerald Global Healthcare Conference
24. September 2018 07:44 ET
|
Biofrontera AG
Leverkusen, Germany, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today announced that Thomas...